Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2005
08/03/2005EP1558650A2 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
08/03/2005EP1558649A1 Peptides modulating caspase activation
08/03/2005EP1558647A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
08/03/2005EP1558646A2 Single domain antibodies directed against interferon- gamma and uses thereof
08/03/2005EP1558645A2 Stabilized single domain antibodies
08/03/2005EP1558599A2 Heteroarylpiperidine modulators of chemokine receptor activity
08/03/2005EP1558595A1 Piperazinyl and diazapanyl benzamides and benzthioamides
08/03/2005EP1558587A1 Heteroaryl-hexanoic acid amide derivatives as immunomodulatory agents
08/03/2005EP1558566A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same
08/03/2005EP1558563A1 Quaternary ammonium compounds
08/03/2005EP1429750A4 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
08/03/2005EP1359975A4 Ocular iontophoretic device and method of use
08/03/2005EP1330455B1 Novel 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same
08/03/2005EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
08/03/2005EP1267899B1 Ssa inactivated salmonella vaccines
08/03/2005EP1237567B1 Method for administering a cytokine to the central nervous system and the lymphatic system
08/03/2005EP1228059B1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
08/03/2005EP1225896B1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors
08/03/2005EP1142890B1 Aminopyrazole derivatives
08/03/2005EP0914435B1 Hybrid interferon compositions and methods of use
08/03/2005EP0851925B1 Human growth hormone variants
08/03/2005EP0639070B1 Use of borate-polyol complexes in ophthalmic compositions
08/03/2005CN1650169A Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/03/2005CN1650020A Means and methods for the production of adenovirus vectors
08/03/2005CN1650014A Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
08/03/2005CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
08/03/2005CN1649898A Novel peptides and the application thereof in therapy
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649876A 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
08/03/2005CN1649870A 7-aryl-3, 9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases
08/03/2005CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases
08/03/2005CN1649864A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649857A Hydroxamic acid derivatives
08/03/2005CN1649855A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
08/03/2005CN1649853A Thiazolidinones compound, its preparing method and use as medicine
08/03/2005CN1649849A Tachykinin receptor antagonists
08/03/2005CN1649848A Fused pyrimidines derivatives as antagonists of the corticotropin releasing factor (CRF)
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649842A 2, 6-quinolinyl and 2, 6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
08/03/2005CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient
08/03/2005CN1649624A Use of TNF alpha antibodies and another drug
08/03/2005CN1649621A Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
08/03/2005CN1649618A Methods
08/03/2005CN1649611A Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
08/03/2005CN1649610A Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and DNA repair proc
08/03/2005CN1649609A Soybean saponin-containing material and process for producing the same
08/03/2005CN1649595A Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
08/03/2005CN1649568A Pharmaceutical compositions for the treatment of asthma
08/03/2005CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
08/03/2005CN1647806A Leadless plaster medium for Chinese medicine and preparing method
08/03/2005CN1647698A Health drink for improving human body immunity
08/03/2005CN1647697A Health food containing chitin and its preparing method
08/03/2005CN1213047C Puring derivatives inhibitors of tyrosine kinase SYK
08/03/2005CN1213036C Novel amide derivatives
08/03/2005CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
08/03/2005CN1212860C Cordyceps sinensis buccal tablets
08/03/2005CN1212839C Use of substituted pyrazoles in preparing medicine for treating allergies
08/03/2005CN1212831C Pharmaceutical preparations
08/02/2005US6924376 Compounds, compositions and methods
08/02/2005US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases
08/02/2005US6924305 Diazocine derivatives and their use as tryptase inhibitors
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
08/02/2005US6924293 Sulfonamide and sulfamide substituted imidazoquinolines
08/02/2005US6924292 Nitrogen compounds such as 2-(methylsulfinyl) N [3-(3,4,8,9-tetrahydro-6-methoxy-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)phenyl]acetamide, used as phosphodiesterase inhibitors; antidiabetics; antiinflammatory agents
08/02/2005US6924288 Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
08/02/2005US6924277 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases
08/02/2005US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
08/02/2005US6924271 Having immunomodulatory activity, for therapy and prophylaxis of diseases
08/02/2005US6924266 NTP-peptides and method for removal of tumors
08/02/2005US6924135 DNA encoding Eimeria glyceroaldehyde-3-phosphate dehydrogenase and uses thereof
08/02/2005US6924118 Recombinant intracellular pathogen immunogenic compositions and methods for use
08/02/2005US6924100 Nucleotide sequences coding preferential polypeptide for use in the treatment and diagnosis of cardiovascular disorders and headaches
08/02/2005US6923988 Solid carrier includes a hydrophililc surfactant and a drug
08/02/2005US6923965 comprises inhibitors of glycosaminoglycans; for wound healing and angiogenesis
08/02/2005US6923959 Method of pre-inducing a state of immune tolerance before organ transplantation
08/02/2005US6923957 Inactivated virulence genes
08/02/2005CA2362339C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/02/2005CA2362337C Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives
08/02/2005CA2332538C Novel 4-phenylpiperidines for the treatment of pruritic dermatoses
08/02/2005CA2170020C Retroviral protease inhibiting compounds
07/2005
07/30/2005CA2495497A1 Compositions for eliciting immune response and methods for using same
07/28/2005WO2005068491A1 Antitumoral and antiviral peptides
07/28/2005WO2005067951A1 Botanical extract composition
07/28/2005WO2005067942A1 Glycosaminoglycan peptides derived from connective tissues and use thereof in the prevention of arthritis and other degenerative medical conditions
07/28/2005WO2005027936A3 Pharmaceutical compositions and therapeutical treatment with oligo-beta-(1, 3)-glucans
07/28/2005WO2003072035A8 Compositions and methods for the treatment of immune related diseases
07/28/2005US20050165243 Process for the production of an immunosuppressant
07/28/2005US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles
07/28/2005US20050165118 Hypotensive agents; antiinflammatory agents; gastrointestinal disorders; autoimmune disease; 4-phenyl pinene derivatives
07/28/2005US20050165113 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia
07/28/2005US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase
07/28/2005US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells
07/28/2005US20050165087 Nf-kb inhibitors
07/28/2005US20050165086 Aminothiophene inhibitors of NF- kappa B inhibitors for treatment of diseases such as cancer or aids
07/28/2005US20050165064 Novel thiol derivative, process for producing the same and use thereof
07/28/2005US20050165056 salt formation; polymorph forms or amorphous forms; antihistamines, antiallergens, bronchodilator agent
07/28/2005US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
1 ... 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 ... 1172